Identification of potential microRNA markers related to Crimean-Congo hemorrhagic fever disease.


Journal

Journal of cellular biochemistry
ISSN: 1097-4644
Titre abrégé: J Cell Biochem
Pays: United States
ID NLM: 8205768

Informations de publication

Date de publication:
09 2019
Historique:
received: 13 12 2018
revised: 20 03 2019
accepted: 22 03 2019
pubmed: 3 5 2019
medline: 12 9 2020
entrez: 3 5 2019
Statut: ppublish

Résumé

Crimean-Congo hemorrhagic fever (CCHF) is a tick-borne disease caused by the arbovirus Crimean-Congo hemorrhagic fever virus (CCHFV). The CCHFV has a single-stranded RNA genome of negative sense. MicroRNAs (miRNAs) are key players in virus-host interactions and viral pathogenesis. We investigated the miRNA gene expression profiles in patients with CCHF using microarray for the first time in the world. Microarray analysis was performed using mirBase Ver 21 (Agilent Technologies, Santa Clara, CA). All statistical analyses were performed across the case-control, fatal-control, and fatal-nonfatal case groups using Genespring (Ver 3.0). Fifteen miRNAs were statistical significant in patients with CCHF compared with the controls (5 were upregulated, 10 were downregulated). Seventy-five and sixty-six miRNAs are in fatal compared with control and nonfatal case, respectively (fold change ([FC] ≥50) were statistically significant. In this study, the target genes of important miRNAs were identified and Gene Ontology analyses were performed across all groups. As a result of this study, we propose that the detection of miRNAs in patients with CCHF will allow the determination of therapeutic targets in diseases. CCHF is an important public health problem that can often be fatal. In this study, we investigated miRNA expression in case-control, fatal-control, and fatal-nonfatal case groups. Significant miRNAs associated with fatality were detected in CCHF. This study will serve as a source of data for the development of an antagomir-based therapy against CCHF using miRNAs in the future.

Identifiants

pubmed: 31044455
doi: 10.1002/jcb.28817
doi:

Substances chimiques

Biomarkers 0
MicroRNAs 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

15506-15517

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Auteurs

Serdal Arslan (S)

Department of Medical Biology, Faculty of Medicine, Sivas Cumhuriyet University, Sivas, Turkey.

Aynur Engin (A)

Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Sivas Cumhuriyet University, School of Medicine, Sivas, Turkey.

Eylem Itir Aydemir (EI)

Department of Statistic, Faculty of Science, Sivas Cumhuriyet University, Sivas, Turkey.

Nil Ozbilum Sahin (NO)

Department of Molecular Biology and Genetic, Faculty of Science, Sivas Cumhuriyet University, Sivas, Turkey.

Burcu Bayyurt (B)

Department of Medical Biology, Faculty of Medicine, Sivas Cumhuriyet University, Sivas, Turkey.

Ismail Sari (I)

Department of Medicinal Biochemistry, Faculty of Medicine, Nigde Omer Halisdemir University, Nigde, Turkey.

Yasemin Cosgun (Y)

Department of Microbiology Reference and Biological Products Laboratories, Ministry of Health, General Directorate of Public Health, Ankara, Turkey.

Mehmet Bakir (M)

Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Sivas Cumhuriyet University, School of Medicine, Sivas, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH